Emerging Infectious Disease Diagnostics Global Market Report 2025

Description

Emerging infectious disease diagnostics involve advanced techniques and tools used to identify new or re-emerging infectious diseases caused by pathogens such as viruses, bacteria, or parasites. These diagnostics utilize cutting-edge technologies, including molecular testing, genomics, and rapid assays, to detect infections with speed and accuracy, thereby enhancing public health responses. They play a vital role in monitoring and controlling outbreaks and in the development of targeted treatments and vaccines.

The primary types of infections addressed by emerging infectious disease diagnostics include viral, bacterial, fungal, and others. Viral infections are diseases caused by viruses, which are minute pathogens that reproduce inside the host's cells. These include respiratory infections, gastrointestinal infections, and sexually transmitted infections (STIs). The technologies used for detection include polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), next-generation sequencing (NGS), and immunodiagnostics, among others. Diagnostics can be applied in laboratory testing and point-of-care testing settings and are utilized by various end-users such as hospitals, clinics, diagnostic laboratories, and others.

The emerging infectious disease diagnostics market research report is one of a series of new reports from The Business Research Company that provides emerging infectious disease diagnostics market statistics, including emerging infectious disease diagnostics industry global market size, regional shares, competitors with a emerging infectious disease diagnostics market share, detailed emerging infectious disease diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the emerging infectious disease diagnostics industry. This emerging infectious disease diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The emerging infectious disease diagnostics market size has grown strongly in recent years. It will grow from $22.13 billion in 2024 to $24.34 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to increasing demand for point-of-care diagnostics, increasing prevalence of infectious diseases, increasing global population density, rising incidence of infectious diseases, and increasing healthcare expenditure.

The emerging infectious disease diagnostics market size is expected to see strong growth in the next few years. It will grow to $35.21 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to the rising incidence of zoonotic diseases, significant growth in regulatory changes and support, development of universal vaccines, increasing focus on one health approach, and rising government support and funding. Major trends in the forecast period include technological advancements, next-generation sequencing (NGS), isothermal amplification techniques, telemedicine and remote diagnostics, and environmental pathogen monitoring.

The increasing incidence of zoonotic diseases is projected to drive the growth of the emerging infectious disease diagnostics market in the future. Zoonotic diseases are infections that can be transmitted from animals to humans and are caused by various pathogens, including bacteria, viruses, parasites, or fungi. The rise in zoonotic diseases is primarily attributed to heightened human-wildlife interactions, habitat destruction, and global travel, which facilitate the transmission of pathogens across species. Emerging infectious disease diagnostics play a crucial role in managing zoonotic diseases by enabling early detection and accurate identification of pathogens. This capability allows for prompt intervention, effective treatment, and improved containment of disease outbreaks, thus reducing transmission from animals to humans. For example, in February 2024, the 2022 Zoonotic Disease Report published by the State of West Virginia, a US-based government agency, noted that the number of reported Lyme disease cases increased to 2,449 in 2022, up from 1,788 cases in 2021. Therefore, the rising incidence of zoonotic diseases is driving the growth of the emerging infectious disease diagnostics market.

Leading companies in this market are focusing on technological advancements, such as molecular diagnostic platforms, to gain a competitive edge. These platforms utilize nucleic acid amplification techniques to detect pathogens with high sensitivity and specificity, enabling accurate and early diagnosis. For instance, in May 2022, Becton Dickinson and Company, a US-based medical equipment manufacturer, introduced the BD COR MX/PX System, a fully automated, high-throughput diagnostic platform. This system enhances laboratory efficiency by automating the entire molecular workflow, from sample processing to result delivery. Its initial assay, the BD CTGCTV2, detects three common non-viral sexually transmitted infections (STIs). The BD COR MX/PX System can process up to 1,700 specimens with onboard reagent and sample capacity, providing over seven hours of continuous operation and delivering up to 1,000 results in 24 hours, significantly reducing manual handling by lab technicians.

In August 2022, Bio-Rad Laboratories Inc., a US-based life science research and clinical diagnostics company, acquired Curiosity Diagnostics for $170 million. This acquisition is notable for Bio-Rad as it enhances their portfolio by integrating Curiosity Diagnostics' PCR|ONE platform, a rapid diagnostics system designed specifically for molecular diagnostics. Curiosity Diagnostics, based in Poland, specializes in molecular diagnostic systems for managing infectious diseases.

Major companies operating in the emerging infectious disease diagnostics market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Hologic Inc., Illumina Inc., bioMerieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Meridian Bioscience Inc., Sekisui Diagnostics LLC, Copan Diagnostics, Co-Diagnostics Inc., T2 Biosystems Inc.

North America was the largest region in the emerging infectious disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the emerging infectious disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the emerging infectious disease diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The emerging infectious disease diagnostics market consists of revenues earned by entities by providing services such as laboratory testing, diagnostic tool development, clinical interpretation of test results, surveillance and reporting, and the provision of telehealth consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. The emerging infectious disease diagnostic market also includes sales of rapid test kits, polymerase chain reaction (PCR) machines, molecular diagnostic assays, sequencing platforms, point-of-care diagnostic devices, and biosensors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Emerging Infectious Disease Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on emerging infectious disease diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for emerging infectious disease diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The emerging infectious disease diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Infection Type: Viral; Bacterial; Fungal; Other Infections
2) By Disease Type: Respiratory Infections; Gastrointestinal Infections; Sexually Transmitted Infections (STIs); Other Disease Types
3) By Technology: Polymerase Chain Reaction (PCR); Isothermal Nucleic Acid Amplification Technology (INAAT); Next-Generation Sequencing (NGS); Immunodiagnostics; Other Technologies
4) By Application: Laboratory Testing; Point-of-Care Testing
5) By End-User: Hospitals And Clinics; Diagnostics Laboratories; Other End-Users
Subsegments:
1) By Viral: Respiratory Viruses; Hepatitis Viruses; HIV and Retroviruses; Arboviruses; Herpesviruses; Gastrointestinal Viruses; Emerging Viral Infections
2) By Bacterial: Tuberculosis (TB); Methicillin-Resistant Staphylococcus Aureus (MRSA); Escherichia Coli (E. coli) Infections; Streptococcus and Pneumococcus Infections; Clostridium Infections; Neisseria; Emerging Drug-Resistant Bacteria
3) By Fungal: Candidiasis; Aspergillosis; Cryptococcosis; Histoplasmosis; Coccidioidomycosis; Pneumocystis Pneumonia (PCP); Emerging Fungal Infections
4) By Other Infections: Parasitic Infections; Protozoan Infections; Prion Diseases; Helminthic Infections; Non-Pathogenic or Environmental Infections
Companies Mentioned: Roche Diagnostics; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33478

1. Executive Summary

2. Emerging Infectious Disease Diagnostics Market Characteristics

3. Emerging Infectious Disease Diagnostics Market Trends And Strategies

4. Emerging Infectious Disease Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Emerging Infectious Disease Diagnostics Growth Analysis And Strategic Analysis Framework

5.1. Global Emerging Infectious Disease Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Emerging Infectious Disease Diagnostics Market Growth Rate Analysis
5.4. Global Emerging Infectious Disease Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Emerging Infectious Disease Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Emerging Infectious Disease Diagnostics Total Addressable Market (TAM)

6. Emerging Infectious Disease Diagnostics Market Segmentation

6.1. Global Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Viral
Bacterial
Fungal
Other Infections
6.2. Global Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Respiratory Infections
Gastrointestinal Infections
Sexually Transmitted Infections (STIs)
Other Disease Types
6.3. Global Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Next-Generation Sequencing (NGS)
Immunodiagnostics
Other Technologies
6.4. Global Emerging Infectious Disease Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Laboratory Testing
Point-of-Care Testing
6.5. Global Emerging Infectious Disease Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Diagnostics Laboratories
Other End-Users
6.6. Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Viral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Respiratory Viruses
Hepatitis Viruses
HIV and Retroviruses
Arboviruses
Herpesviruses
Gastrointestinal Viruses
Emerging Viral Infections
6.7. Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Bacterial, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tuberculosis (TB)
Methicillin-Resistant Staphylococcus Aureus (MRSA)
Escherichia Coli (E. coli) Infections
Streptococcus and Pneumococcus Infections
Clostridium Infections
Neisseria
Emerging Drug-Resistant Bacteria
6.8. Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Fungal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Candidiasis
Aspergillosis
Cryptococcosis
Histoplasmosis
Coccidioidomycosis
Pneumocystis Pneumonia (PCP)
Emerging Fungal Infections
6.9. Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Other Infections, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Parasitic Infections
Protozoan Infections
Prion Diseases
Helminthic Infections
Non-Pathogenic or Environmental Infections

7. Emerging Infectious Disease Diagnostics Market Regional And Country Analysis

7.1. Global Emerging Infectious Disease Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Emerging Infectious Disease Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Emerging Infectious Disease Diagnostics Market

8.1. Asia-Pacific Emerging Infectious Disease Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Emerging Infectious Disease Diagnostics Market

9.1. China Emerging Infectious Disease Diagnostics Market Overview
9.2. China Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Emerging Infectious Disease Diagnostics Market

10.1. India Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Emerging Infectious Disease Diagnostics Market

11.1. Japan Emerging Infectious Disease Diagnostics Market Overview
11.2. Japan Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Emerging Infectious Disease Diagnostics Market

12.1. Australia Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Emerging Infectious Disease Diagnostics Market

13.1. Indonesia Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Emerging Infectious Disease Diagnostics Market

14.1. South Korea Emerging Infectious Disease Diagnostics Market Overview
14.2. South Korea Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Emerging Infectious Disease Diagnostics Market

15.1. Western Europe Emerging Infectious Disease Diagnostics Market Overview
15.2. Western Europe Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Emerging Infectious Disease Diagnostics Market

16.1. UK Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Emerging Infectious Disease Diagnostics Market

17.1. Germany Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Emerging Infectious Disease Diagnostics Market

18.1. France Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Emerging Infectious Disease Diagnostics Market

19.1. Italy Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Emerging Infectious Disease Diagnostics Market

20.1. Spain Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Emerging Infectious Disease Diagnostics Market

21.1. Eastern Europe Emerging Infectious Disease Diagnostics Market Overview
21.2. Eastern Europe Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Emerging Infectious Disease Diagnostics Market

22.1. Russia Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Emerging Infectious Disease Diagnostics Market

23.1. North America Emerging Infectious Disease Diagnostics Market Overview
23.2. North America Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Emerging Infectious Disease Diagnostics Market

24.1. USA Emerging Infectious Disease Diagnostics Market Overview
24.2. USA Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Emerging Infectious Disease Diagnostics Market

25.1. Canada Emerging Infectious Disease Diagnostics Market Overview
25.2. Canada Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Emerging Infectious Disease Diagnostics Market

26.1. South America Emerging Infectious Disease Diagnostics Market Overview
26.2. South America Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Emerging Infectious Disease Diagnostics Market

27.1. Brazil Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Emerging Infectious Disease Diagnostics Market

28.1. Middle East Emerging Infectious Disease Diagnostics Market Overview
28.2. Middle East Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Emerging Infectious Disease Diagnostics Market

29.1. Africa Emerging Infectious Disease Diagnostics Market Overview
29.2. Africa Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Emerging Infectious Disease Diagnostics Market Competitive Landscape And Company Profiles

30.1. Emerging Infectious Disease Diagnostics Market Competitive Landscape
30.2. Emerging Infectious Disease Diagnostics Market Company Profiles
- 30.2.1. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

31. Emerging Infectious Disease Diagnostics Market Other Major And Innovative Companies

31.1. Becton Dickinson and Company
31.2. Laboratory Corporation of America Holdings
31.3. Quest Diagnostics Incorporated
31.4. Agilent Technologies Inc.
31.5. Hologic Inc.
31.6. Illumina Inc.
31.7. bioMerieux SA
31.8. QuidelOrtho Corporation
31.9. Bio-Rad Laboratories, Inc.
31.10. Qiagen N.V.
31.11. DiaSorin S.p.A.
31.12. Randox Laboratories Ltd.
31.13. Meridian Bioscience Inc.
31.14. Sekisui Diagnostics LLC
31.15. Copan Diagnostics

32. Global Emerging Infectious Disease Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Emerging Infectious Disease Diagnostics Market

34. Recent Developments In The Emerging Infectious Disease Diagnostics Market

35. Emerging Infectious Disease Diagnostics Market High Potential Countries, Segments and Strategies

35.1 Emerging Infectious Disease Diagnostics Market In 2029 - Countries Offering Most New Opportunities
35.2 Emerging Infectious Disease Diagnostics Market In 2029 - Segments Offering Most New Opportunities
35.3 Emerging Infectious Disease Diagnostics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
250423_r33478_Emerging_Infectious_Disease_Diagnostics_GMR_2025